3 Things to Know About Cognitive Impairment in Schizophrenia.

The article discusses clinical information and management of cognitive impairment associated with schizophrenia (CIAS). Topics explored include the significant impact of CIAS on the well-being and quality of life of affected individuals, the cognitive impairment categories noted in CIAS such as verb...

Descripción completa

Detalles Bibliográficos
Publicado en:Psychiatric Times Vol. 41; no. 10; pp. 22 - 24
Formato: Artículo
Publicado: MJH Life Sciences Oct2024
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=180060728&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 180060728
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        08932905
        8MJ
      jtl: Psychiatric Times
      issn: 08932905
      maglogo: N
    pubinfo:
      dt: Oct2024
      vid: 41
      iid: 10
      pid: 54670
      pub: MJH Life Sciences
    artinfo:
      ui: 180060728
      ppf: 22
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
            size: 411KB
      tig:
        atl: 3 Things to Know About Cognitive Impairment in Schizophrenia.
      aug:
      su:
        Quality of life
        Well-being
        Activities of daily living
        Drug therapy for schizophrenia
        Parasympathomimetic agents
        Continuing education units
        Cognition disorders
        Muscarinic agonists
      sug:
        subj:
          Quality of life
          Well-being
          Activities of daily living
          Drug therapy for schizophrenia
          Parasympathomimetic agents
          Continuing education units
          Cognition disorders
          Muscarinic agonists
      ab: The article discusses clinical information and management of cognitive impairment associated with schizophrenia (CIAS). Topics explored include the significant impact of CIAS on the well-being and quality of life of affected individuals, the cognitive impairment categories noted in CIAS such as verbal learning and social cognition, and the CIAS treatment options that target N-methyl-D-aspartate (NMDA) receptor neurotransmission.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N